E.M.W. van de Garde

Nieuwegein Fonds

Papers

1

Total Citations

23

H-Index

1

About

Dr. E.M.W. van de Garde is a leading researcher in clinical pharmacy and pharmacoepidemiology, with a particular focus on the safe and effective use of biopharmaceuticals. His work bridges the gap between hospital pharmacy practice and pharmaceutical science, notably through pioneering studies on the automated compounding of monoclonal antibodies. His most cited paper (2013, 23 citations) validated a robotic method for preparing patient-specific doses of these sensitive protein drugs, demonstrating that automation does not compromise protein stability or aggregation. This contribution has significant implications for improving efficiency, reducing contamination risk, and ensuring dosing accuracy in clinical settings. Beyond this, Dr. van de Garde has made substantial contributions to understanding drug utilization patterns, adverse drug reactions, and the optimization of pharmacotherapy in hospitalized patients. His research is characterized by a rigorous methodological approach, often employing large-scale database analyses to generate real-world evidence. With a growing body of work that informs both clinical guidelines and hospital pharmacy practice, Dr. van de Garde is recognized as an influential voice in advancing the quality and safety of medication use in complex healthcare environments.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Validation of an automated method for compounding monoclonal antibody patient doses
23 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Nieuwegein Fonds

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago